Dongguk University Ilsan Hospital Completes First Brain Tumor Treatments With the ZAP-X Gyroscopic Radiosurgery Platform
Installation Marks the Second ZAP-X System in Korea to Offer the Latest Advance in Non-Surgical Brain Tumor CareGOYANG-SI, South Korea--(BUSINESS WIRE)--ZAP Surgical Systems, Inc., a global leader in
Loss-Making Accuray Incorporated (NASDAQ:ARAY) Expected To Breakeven In The Medium-Term
Express News | Long-term Customer Heidelberg University Hospital In Heidelberg, Germany, Has Selected Accuray's Radixact System, Equipped With ClearRT, Synchrony, And VOLO Ultra Optimizer Solutions, It Will Replace The Older Generation Accuray Tomotherapy System
Express News | Heidelberg University Hospital in Germany Invests in Fourth Accuray Radiotherapy Device, the Radixact® System, to Improve Cancer Patient Care
Les Centres De Cancérologie Apollo Collaborent Avec Accuray Pour Lancer Le Premier Programme De Radiothérapie Stéréotaxique Robotisée Du Sous-continent Indien
Le programme favorisera le développement des soins oncologiques, faisant ainsi progresser le paysage sanitaire de la région. Les participants prendront part à des discussions et à des démonstrat
Apollo Cancer Centres Collaborates With Accuray to Launch India Sub- Continent's First Robotic Stereotactic Radiotherapy Program
Apollo Cancer Centres (ACC), in association with Accuray, a global provider of radiation therapy devices, today announced the launch of India...
Accuray (ARAY), TrueNorth Unite to Aid Radiation Departments
Express News | Accuray Announced An Agreement With TrueNorth Medical Physics To Provide Radiation Oncology Departments With Third-party Support Designed To Enhance Their Department's Capabilities
Express News | Accuray and Truenorth Medical Physics Sign Agreement to Provide Radiation Oncology Support Intended to Advance Cancer Care for More Patients
Accuray's (ARAY) Precision TPS Gets Approved by China's NMPA
Accuray's Precision Treatment Planning System Gains Approval in China
Lake Street Maintains Accuray(ARAY.US) With Buy Rating, Maintains Target Price $6
Lake Street analyst Brooks O'Neil maintains $Accuray(ARAY.US)$ with a buy rating, and maintains the target price at $6.According to TipRanks data, the analyst has a success rate of 44.5% and a total a
Accuray Precision TPS' Registration Dossier Approved in China
Express News | Accuray Announces Approval of the Accuray Precision® Treatment Planning System by China's National Medical Products Administration
Accuray(ARAY.US) Officer Sells US$4,597.1 in Common Stock
$Accuray(ARAY.US)$ Officer Pervaiz Ali sold 2,701 shares of common stock on Jun 4, 2024 at an average price of $1.702 for a total value of $4,597.1.Source: Announcement What is statement of changes in
Independent Chairman of the Board of Accuray Joseph Whitters Buys 25% More Shares
Investors who take an interest in Accuray Incorporated (NASDAQ:ARAY) should definitely note that the Independent Chairman of the Board, Joseph Whitters, recently paid US$1.56 per share to buy US$156k
Director Joseph Whitters Acquires 100,000 Shares of Accuray Inc (ARAY)
Accuray(ARAY.US) Director Buys US$156.05K in Common Stock
$Accuray(ARAY.US)$ Director WHITTERS JOSEPH E purchased 100K shares of common stock on May 28, 29, 2024 at an average price of $1.5605 for a total value of $156.05K.Source: Announcement What is statem
12 Health Care Stocks Moving In Thursday's After-Market Session
GainersMyMD Pharmaceuticals (NASDAQ:MYMD) stock rose 46.0% to $2.89 during Thursday's after-market session. The market value of their outstanding shares is at $6.6 million. Adaptimmune Therapeutics (N
Accuray to Participate in the Jefferies Global Healthcare Conference 2024
Accuray Incorporated (NASDAQ: ARAY) announced today its participation in the Jefferies Global Healthcare Conference 2024. The management team is...